Dodgers expected to name Dave Roberts as manager

11 Comments

Update (11:00 PM EST): Roberts will sign a three-year deal to manage the Dodgers, per Bob Nightengale of USA TODAY. The press conference will be held a week after Thanksgiving.

*

The Dodgers are expected to name former major leaguer Dave Roberts as manager, Dylan Hernandez, Bill Plaschke, and Bill Shaikin of the Los Angeles Times are reporting. The hiring is expected to be made official on Monday.

Roberts, 43, spent parts of 10 seasons in the majors with the Indians, Dodgers, Red Sox, Padres, and Giants. He made a name for himself with his speed, swiping 243 bases in 301 attempts (80.7%). Following his retirement, Roberts had been coaching for the Padres since 2011 and officially managed one game in 2015 after Bud Black was fired and before Pat Murphy took over in the interim.

Roberts is one of three minority managers, joining Dusty Baker and Fredi Gonzalez. He’s the Dodgers’ first minority manager. Baker, recently hired to manage the Nationals, lamented the lack of diversity in baseball.

Gabe Kapler was the other finalist for the Dodgers’ open managerial position.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.